Delivery Order SPE2DB20D2104-SPE2DB26FMAXH
- Not listed
- The U.S. government awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,097,842 units of Amlodipine Besylate 10 mg tablets. The contract, worth $1,294.56, has a performance period through March 28, 2024 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,618,101 tablets of Amlodipine Besylate 10 mg, a generic blood pressure medication. The contract has a potential value of $1,067.80 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide the pharmaceutical product from their...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $47,640 to Amerisourcebergen Drug Corporation for 1,000 tablets of amlodipine besylate 5 mg. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is from August 17 to August 18, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a common hypertension medication supports the Defense Logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $414.35 to Amerisourcebergen Drug Corporation for 1,000 tablets of 10mg amlodipine besylate. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the specified...
- The Defense Logistics Agency awarded a $171,480 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 boxes of 10mg amlodipine besylate tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility by September 19, 2023 in support of the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were indicated. The delivery order was issued against an existing DLA...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $634 to AmerisourceBergen Drug Corporation for 1,000 tablets of 10 mg amlodipine besylate. The order is to be fulfilled by AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with performance required between September 8-11, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the global supply chain for the U.S. military and supports its...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at three hundred eighty-four dollars and thirty-two cents to Amerisourcebergen Drug Corporation for one thousand tablets of amlodipine besylate 10mg. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order for a common hypertension medication...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $134,000 to Amerisourcebergen Drug Corporation for 1,000 tablets of 10mg amlodipine besylate. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania within the period of performance between August 8-9, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely...
- The Defense Logistics Agency awarded a $5,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 2.5 mg amlodipine besylate. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility by September 1, 2023 in support of the Defense Logistics Agency's medical supply needs. No additional details were provided regarding the solicitation or any overarching contracts under which this delivery order was issued.
- The Defense Logistics Agency awarded a delivery order valued at $1,138.04 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count) on June 20, 2025, with an ultimate completion date of June 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAXHDelivery Order
The Defense Logistics Agency awarded a $1,041.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Amlodipine Besylate 10 mg, with an ultimate completion date of October 27, 2025. This competitive award, which was not set-aside, represents a routine pharmaceutical supply transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Amlodipine Besylate is a calcium channel blocker used to treat hypertension and angina, making it a critical pharmaceutical commodity for military and veteran healthcare systems. This delivery order exemplifies the type of routine medical procurement executed under AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with DLA, which supports the Defense Health Agency and other federal healthcare programs globally. The company's role as a major pharmaceutical distributor positions it to fulfill diverse medical supply requirements across multiple therapeutic domains for the Department of Defense and related health services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/24/25 |